These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29956594)

  • 1. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.
    Shen X; Zhang P; Wang J; An Y; Gregg EW; Zhang B; Li H; Gong Q; Chen Y; Shuai Y; Engelgau MM; Hu Y; Bennett PH; Li G
    Int J Stroke; 2018 Dec; 13(9):941-948. PubMed ID: 29956594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
    Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 9. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Gregg EW; Wang J; An Y; Zhang P; Yang W; Li H; Li H; Jiang Y; Shuai Y; Zhang B; Zhang J; Gerzoff RB; Roglic G; Hu Y; Li G; Bennett PH
    Diabetologia; 2011 Feb; 54(2):300-7. PubMed ID: 21046360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte telomere length is inversely associated with post-load but not with fasting plasma glucose levels.
    Khalangot M; Krasnienkov D; Vaiserman A; Avilov I; Kovtun V; Okhrimenko N; Koliada A; Kravchenko V
    Exp Biol Med (Maywood); 2017 Apr; 242(7):700-708. PubMed ID: 28299976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.
    Pan XR; Hu YH; Li GW; Liu PA; Bennett PH; Howard BV
    Diabetes Care; 1993 Jan; 16(1):150-6. PubMed ID: 8422770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.
    Yu L; Wang J; Gong Q; An Y; Chen F; Chen Y; Chen X; He S; Qian X; Chen B; Dong F; Li H; Zhao F; Zhang B; Li G;
    Diabetes Obes Metab; 2024 Apr; 26(4):1188-1196. PubMed ID: 38168886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
    Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
    Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of development of diabetes mellitus in Chinese women with persistently impaired glucose tolerance after gestational diabetes.
    Lee KF; Mak MW; Lau KO; Chung H
    Hong Kong Med J; 2011 Jun; 17(3):195-201. PubMed ID: 21636867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.
    Kanaya AM; Barrett-Connor E; Gildengorin G; Yaffe K
    Arch Intern Med; 2004 Jun; 164(12):1327-33. PubMed ID: 15226167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.